GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Wohua Pharmaceutical Co Ltd (SZSE:002107) » Definitions » EV-to-Revenue

Shandong Wohua Pharmaceutical Co (SZSE:002107) EV-to-Revenue : 2.72 (As of May. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Shandong Wohua Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shandong Wohua Pharmaceutical Co's enterprise value is ¥2,423.8 Mil. Shandong Wohua Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥889.5 Mil. Therefore, Shandong Wohua Pharmaceutical Co's EV-to-Revenue for today is 2.72.

The historical rank and industry rank for Shandong Wohua Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SZSE:002107' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.61   Med: 4.76   Max: 37.69
Current: 2.72

During the past 13 years, the highest EV-to-Revenue of Shandong Wohua Pharmaceutical Co was 37.69. The lowest was 1.61. And the median was 4.76.

SZSE:002107's EV-to-Revenue is ranked worse than
55.7% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs SZSE:002107: 2.72

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Shandong Wohua Pharmaceutical Co's stock price is ¥4.94. Shandong Wohua Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.64. Therefore, Shandong Wohua Pharmaceutical Co's PS Ratio for today is 3.01.


Shandong Wohua Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Shandong Wohua Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Wohua Pharmaceutical Co EV-to-Revenue Chart

Shandong Wohua Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.35 4.42 4.30 3.30 3.44

Shandong Wohua Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 3.17 3.35 3.44 2.66

Competitive Comparison of Shandong Wohua Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Wohua Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Wohua Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Wohua Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shandong Wohua Pharmaceutical Co's EV-to-Revenue falls into.



Shandong Wohua Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shandong Wohua Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2423.802/889.542
=2.72

Shandong Wohua Pharmaceutical Co's current Enterprise Value is ¥2,423.8 Mil.
Shandong Wohua Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥889.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Wohua Pharmaceutical Co  (SZSE:002107) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shandong Wohua Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.94/1.643
=3.01

Shandong Wohua Pharmaceutical Co's share price for today is ¥4.94.
Shandong Wohua Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.64.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Wohua Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shandong Wohua Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Wohua Pharmaceutical Co (SZSE:002107) Business Description

Traded in Other Exchanges
N/A
Address
Fushou East Street, Chuangye Building, 2F, New and High-Tech Industrial Development Zone, Huaifang, Shandong, CHN, 261011
Shandong Wohua Pharmaceutical Co Ltd is a China-based company specializing in the field of cardio-cerebral vascular medicine. The company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Naoxueshu oral liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza, among others.

Shandong Wohua Pharmaceutical Co (SZSE:002107) Headlines

No Headlines